Skip to content

Clinical trials

Completed Observational Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Observational Status: Completed Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20084
20091
20111
20124
20142
20171
20183
20193
20204
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology4
ECOG-ACRIN Cancer Research Group3
Fudan University3
Geneplus-Beijing Co. Ltd.2
Mayo Clinic2
Alaunos Therapeutics1
AstraZeneca1
Central Hospital, Nancy, France1
Dana-Farber Cancer Institute1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung29
Lung Neoplasms15
Carcinoma, Non-Small-Cell Lung13
Adenocarcinoma, Bronchiolo-Alveolar3
Lung Diseases2
Cholangiocarcinoma1
Colonic Neoplasms1
Colorectal Neoplasms1
Disease Progression1
Neoplasm Metastasis1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.